

FDA issued a warning letter dated 8 June 2026 to Amie Health, Inc. dba Amie (reference MARCS-CMS 728276), following a review of tryamie.com in March 2026. The agency found the site's claims about its compounded semaglutide and tirzepatide products false or misleading, misbranding them under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. Two problems were cited. The compounded products pictured on the site carry an "amie" label, "suggesting Amie is the compounder of those drugs when in fact it is not". And the site claimed that "Ozempic, Mounjaro, and Wegovy contain the same active ingredients as our compounded versions" and that "all our treatments use FDA-approved active ingredients" - the sameness framing the FDA has repeatedly said misbrands a compounded product.
A warning letter is not a finding of harm and does not mean the medication you receive is unsafe. It is a regulator formally telling a company that specific claims on its website broke the law. We report it because it is a matter of public record, it is verifiable at the source, and it is the kind of thing that never appears in a provider's own marketing.
How we make money. GLP-1 Planet earns a commission if you sign up through the links on this page. That does not change what we write, but you should know it before you read on. See our affiliate disclosure.
These plans are compounded, not FDA-approved. Amie's headline pricing covers compounded semaglutide and tirzepatide, mixed by licensed US pharmacies. Compounded drugs are overseen by state boards of pharmacy and are not reviewed or approved by the FDA for safety, efficacy or quality. They share an active ingredient with the branded products, but they are not the same product and are not interchangeable with them.
Where the weight-loss numbers come from. The figures quoted across the industry come from trials of the branded drugs, not compounded copies and not this provider's patients. In STEP 1, adults with a BMI of 30+ (or 27+ with a weight-related condition and no diabetes) taking semaglutide 2.4 mg lost a mean of 14.9% of body weight over 68 weeks. In SURMOUNT-1, a comparable population taking tirzepatide 15 mg lost a mean of 20.9% over 72 weeks. Your results may differ, and no provider can promise a specific outcome.
Who should not take these medications. GLP-1 and GIP/GLP-1 drugs carry a boxed warning for thyroid C-cell tumors and should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. They are not for use in pregnancy or while trying to conceive, and need careful discussion if you have had pancreatitis, gallbladder disease, severe gastrointestinal disease or diabetic retinopathy. Common side effects include nausea, vomiting, diarrhea, constipation, reduced appetite, headache and fatigue.
This review is informational only and is not medical advice. Talk to a licensed clinician before starting, stopping or changing any treatment.
Amie is a popular GLP-1 medication provider offering both semaglutide and tirzepatide for weight loss. With a 6.5/10 rating, Amie maintains a strong reputation in the telemedicine industry. With a monthly price of just $99, Amie positions itself as an affordable option in the competitive GLP-1 market.
The platform provides accessible GLP-1 medications through an online platform. Offering both Amie tirzepatide and semaglutide as part of their Amie GLP-1 medication program gives patients and their healthcare providers flexibility to choose the best treatment based on individual needs and response. Whether you've been researching Amie reviews, Amie reviews complaints, or asking "is Amie legit," you'll find that Amie delivers legitimate, high-quality telemedicine services with licensed healthcare providers.
Amie does not publish a customer phone number on its website; support runs through your account, not published. Amie operates with full transparency, HIPAA compliance, and a commitment to helping patients achieve their weight loss goals safely and effectively.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
$99/month on the monthly plan, or $83/month billed as $249 every 3 months.
At $99/month, Amie offers one of the most competitive pricing options in the GLP-1 market. This makes it an attractive choice for those looking for affordable access to weight loss medications.
Fill out a comprehensive medical questionnaire about your health history, weight loss goals, and current medications.
A licensed healthcare provider reviews your information and determines if GLP-1 medication is right for you.
Your prescription is shipped directly to your door with clear instructions and ongoing support.
What follows is what Amie states on its own website. Where the company does not publish an answer, we say so rather than assume the industry norm applies.
Compounded. The FDA warning letter specifically objects to the site presenting its compounded products as containing the same active ingredients as Ozempic, Mounjaro and Wegovy.
Semaglutide (brand names Wegovy and Ozempic) is a GLP-1 receptor agonist that has been shown to help people lose an average of 15% of their body weight. It works by reducing appetite, slowing digestion, and helping you feel full longer. Amie's standard plans use a compounded version of this ingredient, which is not FDA-approved.
Tirzepatide (brand names Mounjaro and Zepbound) is a dual GIP/GLP-1 receptor agonist that has demonstrated even more significant weight loss results, with clinical trials showing an average of 20% body weight reduction. It offers a dual-action approach to weight management. Amie's standard plans use a compounded version of this ingredient, which is not FDA-approved.
Amie is particularly well-suited for:
Not published
Not published
Not available
Not published
None published
Monthly or 3-month plans; terms not summarised on the pricing panel
Amie is a cash-pay service and does not bill insurance. The company does not publish whether HSA or FSA cards are accepted, so check before you sign up if you plan to pay that way.
Yes, Amie is a legitimate telemedicine provider offering GLP-1 medications for weight loss. Amie operates with licensed healthcare providers and follows all regulatory requirements for prescribing and dispensing medications. With a 6.5/10 rating, Amie maintains a solid reputation in the telemedicine industry.
Many people ask "is Amie legitimate?" or "is Amie a scam?" - these concerns are natural when considering online healthcare services. However, Amie is a fully legitimate medical service that employs licensed physicians, maintains HIPAA compliance, and dispenses medication through licensed US pharmacies. Note that its standard plans are compounded preparations, which are not FDA-approved - a legal category of medicine, but not the same thing as the branded drug.
Amie offers both semaglutide and tirzepatide (Amie tirzepatide is available as part of their comprehensive GLP-1 medication program). Amie GLP-1 medications include:
Both Amie GLP-1 options are available at the competitive price of $99/month, making them accessible for most patients seeking weight loss treatment.
You can reach Amie through multiple channels:
The Amie customer support team is available Not published to answer your questions about their GLP-1 weight loss programs.
Compounded. The FDA warning letter specifically objects to the site presenting its compounded products as containing the same active ingredients as Ozempic, Mounjaro and Wegovy.
$99/month on the monthly plan, or $83/month billed as $249 every 3 months.
When researching "Amie reviews," it's important to look at multiple sources. Here's what we found about Amie reviews and complaints:
Amie has earned a solid 6.5/10 rating based on pricing, service quality, medication options, and customer support. This places Amie among the well-rated GLP-1 providers in the market.
Like any healthcare provider, some customers search for "Amie reviews complaints" or "Amie reviews and complaints" to understand potential issues. While Amie maintains a strong reputation, here's what to know:
When searching for "Amie reviews Consumer Reports" or "Amie reviews consumer reports complaints," remember that independent review platforms provide valuable insights. Amie's rating of 6.5/10 reflects consistent customer feedback across multiple evaluation criteria.
Whether you're searching for "Amie reviews" or "Amie reviews complaints," our comprehensive analysis shows that Amie delivers on its promises of affordable, high-quality GLP-1 weight loss medication with solid customer support.
If Amie is not the right fit, these providers are the closest comparisons on medication and price. Each links to its own review, or you can put the two side by side.
What the trials actually showed, how the two drugs differ, and which one suits which patient.
What compounded actually means, why the price gap has narrowed, and the questions to ask first.
Every pricing model in the market, decoded - and why the advertised number is rarely the real one.
The BMI thresholds, the contraindications that rule people out, and what providers actually check.
This review is editorial research, not medical advice. GLP-1 medications are prescription drugs with real risks and contraindications, and nothing here should be used to decide whether to start, stop or change a treatment. Only a licensed clinician who knows your history can tell you whether Amie - or any GLP-1 medication - is appropriate for you. If you think you are having a serious reaction to a medication, contact a healthcare professional or emergency services.
Prices, policies and medication availability change often in this market. We report what Amie published on its own site at the time of review; confirm the current terms with the provider before you buy.